Exhale

The official blog of the Lung Institute.

What is the Cause of Pneumoconiosis?

What is the Cause of Pneumoconiosis?

Pneumoconiosis describes several occupational lung diseases that are caused by prolonged exposure to irritants like mineral dusts and particles. It is a type of interstitial lung disease, which is characterized by lung inflammation from inhaled substances that settle deep into the lungs. Pneumoconiosis primarily affects coal miners, iron foundry workers, millers, carpenters and employees in related industries who have worked in their respective trades for several years.

There are three main types of pneumoconiosis, each with separate causes:

  • Black lung disease – Also referred to as coal worker’s pneumoconiosis (CWP), black lung is caused by the inhalation of coal dust.
  • Silicosis – Exposure to silica, a mineral dust found in rocks, sand and mineral ores, can lead to silicosis.
  • Siderosis – Breathing in dust that contains iron particles can cause siderosis, also known as welder’s lung.

It is important to note that individuals who have had occasional exposure to coal dust, silica or iron particles are not at high risk for pneumoconiosis. This disease is caused by frequent, prolonged exposure to such substances. Fortunately, government-imposed safety measures and exposure limits have generally reduced the incidence of siderosis and silicosis, although black lung disease has surprisingly spiked in recent years.

There is no cure for pneumoconiosis. However, the Lung Institute offers an alternative for patients who are struggling to manage their symptoms with traditional treatment methods alone. Autologous cellular therapy has the potential to reduce lung inflammation, preserve lung function and even slow the progression of pneumoconiosis. This natural treatment utilizes the patient’s own cells to promote healing and improve quality of life.

No matter what has caused your pneumoconiosis, we encourage you to contact the Lung Institute to explore your alternative treatment options and learn how cellular therapy may help you breathe easier. To speak with a member of our compassionate medical team, call (800) 729-3065 today.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.